Zanamivir for the treatment of avian influenza infections in humans.

about

Treatment options for H5N1: lessons learned from the H1N1 pandemic.Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats

P2860

Q30394018-FC9CE69A-37EC-46B8-BFEB-E17FFB944330 Q37145564-BAE33537-10F8-4429-9260-75366BBE4E27

P2860

Zanamivir for the treatment of avian influenza infections in humans.

Item

http://www.wikidata.org/entity/Q42723628

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Zanamivir for the treatment of avian influenza infections in humans.

@en

Zanamivir for the treatment of avian influenza infections in humans.

@nl

type

Item

label

Zanamivir for the treatment of avian influenza infections in humans.

@en

Zanamivir for the treatment of avian influenza infections in humans.

@nl

prefLabel

Zanamivir for the treatment of avian influenza infections in humans.

@en

Zanamivir for the treatment of avian influenza infections in humans.

@nl

P1476

Zanamivir for the treatment of avian influenza infections in humans.

@en

P2093

Phillip Andrew Reece

http://www.w3.org/2001/XMLSchema#string

P2860

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam

What is the optimal therapy for patients with H5N1 influenza?

Oseltamivir resistance during treatment of influenza A (H5N1) infection

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

Zanamivir-resistant influenza viruses with a novel neuraminidase mutation

Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice.

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.

Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection.

Reduced sensitivity of influenza A (H5N1) to oseltamivir

P304

25-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECP.09.60

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22111530

http://www.w3.org/2001/XMLSchema#string

Zanamivir for the treatment of avian influenza infections in humans.

about

P2860

P2860

Zanamivir for the treatment of avian influenza infections in humans.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698